• Explore /
  • Poster
  • / Prospective evaluation of pathologic response with neoadjuvant chemo-immunotherapy in metaplastic breast cancer.

Prospective evaluation of pathologic response with neoadjuvant chemo-immunotherapy in metaplastic breast cancer.

Abstract Poster

Authors

Nour Abuhadra

Nour Abuhadra

Memorial Sloan Kettering Cancer Center, New York, NY

Nour Abuhadra , Yuan Chen , George Plitas , Pedram Razavi , Fresia Pareja , Jorge S. Reis-Filho , Hannah Yong Wen , Atif J. Khan , Tiffany A. Traina , Stephanie Downs-Canner , Mark E. Robson , Larry Norton , Giacomo Montagna

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 606)

DOI

10.1200/JCO.2023.41.16_suppl.606

Abstract #

606

Poster Bd #

436

Abstract Disclosures

Similar Posters

Poster

2020 ASCO Virtual Scientific Program

Neoadjuvant nivolumab (N) plus cisplatin (C)/pemetrexed (P) or cisplatin /gemcitabine (G) in resectable NSCLC.

Neoadjuvant nivolumab (N) plus cisplatin (C)/pemetrexed (P) or cisplatin /gemcitabine (G) in resectable NSCLC.

First Author: Ralph Zinner

First Author: Antonella Cammarota

First Author: Xiangdong Cheng

First Author: Robert L. Ferris